Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.

Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...

Asian currencies also slumped after the dollar rallied on Trump's sweeping tariffs that impose a 25% levy on Mexican and ...

Experts share insights and opinions on operational technology (OT) cybersecurity risks and how defenders can best protect ...

Australia has banned DeepSeek from all government devices on the advice of security agencies, a top official said Wednesday, ...

Small lenders beset by the fallout from high interest rates took losses in the fourth quarter when they unloaded ...

I’ve been in the content management space for over 17 years, and I’ve seen how it’s changed—especially in financial services.

Asset managers and fintechs face new compliance rules as €35m (US$36.2m) penalties loom for breaches of EU's sweeping AI ...

Pro Medicus is in a strong financial position. As of June 2024, it had AUD 155 million in net cash, and we forecast the company to continue holding net cash over our explicit 10-year forecast period.

Investors often need to keep some money aside for a specific purpose, such as a new vehicle or home repairs. Other times, an investor simply doesn't want to put all his or her money at risk in ...

Tulsi Gabbard, whom Trump has proffered for director of the office of national intelligence, was a staunch defender of one of the world’s most hated dictators. In 2019, she said Syria’s Bashar ...

Syria is seeking to import oil via local intermediaries after its first post-Assad import tenders garnered little interest ...